Ignite Creation Date:
2024-05-06 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 2:49 PM
Study NCT ID:
NCT05690542
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-01-19
First Post:
2023-01-10
Brief Title:
Nanoparticles in Blood Understanding and Controlling Protein Corona for Optimized Nanomedicine
Sponsor:
Centre Hospitalier Universitaire Dijon
Organization:
Centre Hospitalier Universitaire Dijon
Study Overview
Official Title:
Nanoparticles in Blood Understanding and Controlling Protein Corona for Optimized Nanomedicine
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NANOBLORONA
Brief Summary:
The main objective is to study the effect of engineered nanoparticles SPIONs superparamagnetic iron oxide on hemostasis Nanoparticles will be incubated in blood and platelet aggregation will be measured In parallel nanoparticles will also be incubated in blood and then plasma proteins adsorbed on them will be separated and analyzed The proteins found on the nanoparticles will be linked to the platelet aggregation observed to help developing innovative protein functionalized nanoprobes for optimized nanomedicine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None